Cynomolgus PRLR Protein

Recombinant Cynomolgus PRLR Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Gln25-Thr236. Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers.